Synthesis and Anti-Angiogenic Activity of Novel c(RGDyK) Peptide-Based JH-VII-139-1 Conjugates.

Leonidis, George; Koukiali, Anastasia; Sigala, Ioanna; Tsimaratou, Katerina; Beis, Dimitris; Giannakouros, Thomas; Nikolakaki, Eleni; Sarli, Vasiliki

Leonidis, George; Koukiali, Anastasia; Sigala, Ioanna; Tsimaratou, Katerina; Beis, Dimitris; Giannakouros, Thomas; Nikolakaki, Eleni; Sarli, Vasiliki.

Afiliação

Leonidis G; Department of Chemistry, Aristotle University of Thessaloniki, University Campus, 54124 Thessaloniki, Greece.
Koukiali A; Department of Chemistry, Aristotle University of Thessaloniki, University Campus, 54124 Thessaloniki, Greece.
Sigala I; Department of Chemistry, Aristotle University of Thessaloniki, University Campus, 54124 Thessaloniki, Greece.
Tsimaratou K; Zebrafish Disease Model Laboratory, Biomedical Research Foundation Academy of Athens, 11527 Athens, Greece.
Beis D; Zebrafish Disease Model Laboratory, Biomedical Research Foundation Academy of Athens, 11527 Athens, Greece.
Giannakouros T; Department of Chemistry, Aristotle University of Thessaloniki, University Campus, 54124 Thessaloniki, Greece.
Nikolakaki E; Department of Chemistry, Aristotle University of Thessaloniki, University Campus, 54124 Thessaloniki, Greece.
Sarli V; Department of Chemistry, Aristotle University of Thessaloniki, University Campus, 54124 Thessaloniki, Greece.

Pharmaceutics ; 15(2)2023 Jan 22.

Article em En | MEDLINE | ID: mdl-36839704

Palavras-chave

PDCs; RGD peptide; SRPK1; angiogenesis; cancer; hybrid molecules; integrins; peptide drug conjugates; receptor-mediated endocytosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Pharmaceutics Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Grécia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google